← Leaderboards
Angela L. Roger
Duke University
$709,328
Attributed
$709,328
Total exposure
2
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $249K · FY2022–25$250K$187.5K$125K$62.5K$0
'22
'23
'24
'25
Funding mix
By agency
NIH$709,328 · 2
By mechanism
R00$498,000 · 1
K99$211,328 · 1
Top collaborators
No co-investigators on record.
Most similar at Duke University
Same institution · by research overlap
- Dwight D Koeberl$10,403,079
- Priya S. Kishnani$1,826,678
- Harvey E Marshall$3,955,040
- Yuan T Chen$792,683
- Eva Nozik Grayck$11,896,272
Others in their field
Other Rising Stars on “Experimental Study”
- Mari Ostendorf · University Of Washington$51,931,230
- Julia Louise Moore Vogel · Scripps Research Institute, The$32,252,685
- Samuel W Teitelbaum · Arizona State University$13,377,213
- Jason Dickens · Duke University$12,259,409
- Suma Babu · Massachusetts General Hospital$11,004,714
- Sabrina Paganoni · Massachusetts General Hospital$11,004,714
Research focus
Experimental StudyAffectEnzyme Replacement TherapyEnzymesAutophagocytosisAutophagosomeBloodAdeno-Associated Viral VectorAcuteEnvironmentBreathingCardiacCareerCell TherapyChildhoodClinical CareArchitectureClinical TreatmentClinical TrialsAutomobile DrivingComplexBrainDistressFda Approved
Grant awards (4)
Novel Adjunctive Therapies for Pompe Disease$249,000
R00 · FY2025 · HL · contact PI
Novel Adjunctive Therapies for Pompe Disease$249,000
R00 · FY2024 · HL · contact PI
Novel Adjunctive Therapies for Pompe Disease$105,664
K99 · FY2023 · HL · contact PI
Novel Adjunctive Therapies for Pompe Disease$105,664
K99 · FY2022 · HL · contact PI